← Leaderboards
Rami Kantor
Stanford University
$14,799,482
Attributed
$21,964,200
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,964,200 · 12
By mechanism
R01$18,632,307 · 6
K24$1,087,818 · 1
P30$1,077,959 · 3
R37$748,860 · 1
R21$417,256 · 1
Top collaborators
- Rachel Christine Vreeman10 shared
- David Allenberg Katzenstein8 shared
- Joseph W Hogan5 shared
Most similar at Stanford University
Same institution · by research overlap
- Robert W Shafer$16,663,491
- David Allenberg Katzenstein$5,157,240
- Mathew Vinhhoa Kiang$1,106,164
- Thomas N Robinson$40,790,008
- Gregory George Zaharchuk$14,220,326
Others in their field
Top investigators on “Drug Resistance”
- Judith S. Currier · University Of California Los Angeles$207,752,958
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,910,108
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Daniel R Kuritzkes · Brigham And Women'S Hospital$114,882,802
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,453,088
Research focus
Drug ResistanceResourcesAntiretroviral TherapyHiv Drug ResistanceMonitorDesignTreatment FailureTransmission ProcessSamplingCollaborationsInnovationPatient CareFundingRegimenGuidelinesEpidemicProgramsCaringResistancePharmaceutical PreparationsUnited States National Institutes Of HealthAnti-Retroviral AgentsPublic HealthCohort
Grant awards (43)
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission$748,860
R37 · FY2025 · AI · contact PI
HIV Drug Resistance in the New Antiretroviral Therapy Era in Kenya$502,412
R01 · FY2025 · AI · contact PI
Core H - Basic Science Core$229,607
P30 · FY2025 · AI · contact PI
HIV drug resistance, monitoring and transmission$196,366
K24 · FY2025 · AI · contact PI
HIV Drug Resistance in the New Antiretroviral Therapy Era in Kenya$181,923
R01 · FY2025 · AI · contact PI
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents$686,299
R01 · FY2024 · AI · contact PI
HIV Drug Resistance in the New Antiretroviral Therapy Era in Kenya$645,900
R01 · FY2024 · AI · contact PI
Core H - Basic Science Core$226,268
P30 · FY2024 · AI · contact PI
HIV drug resistance, monitoring and transmission$196,366
K24 · FY2024 · AI · contact PI
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents$692,995
R01 · FY2023 · AI · contact PI
Core H - Basic Science Core$263,257
P30 · FY2023 · AI · contact PI
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents$700,042
R01 · FY2022 · AI · contact PI
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission$647,743
R01 · FY2022 · AI · contact PI
HIV Drug Resistance, Monitoring and Transmission$138,522
K24 · FY2022 · AI · contact PI
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission$661,625
R01 · FY2021 · AI · contact PI
HIV Drug Resistance, Monitoring and Transmission$138,735
K24 · FY2021 · AI · contact PI
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents$967,487
R01 · FY2020 · AI · contact PI
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission$673,502
R01 · FY2020 · AI · contact PI
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents$166,607
R01 · FY2020 · AI · contact PI
HIV Drug Resistance, Monitoring and Transmission$138,943
K24 · FY2020 · AI · contact PI
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents$733,086
R01 · FY2019 · AI · contact PI
HIV Treatment Failure and Drug Resistance in Western Kenyan Children$719,958
R01 · FY2019 · AI
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission$691,359
R01 · FY2019 · AI · contact PI
Optimizing HIV Treatment Monitoring under Resource Constraints$663,842
R01 · FY2019 · AI
HIV Drug Resistance, Monitoring and Transmission$139,149
K24 · FY2019 · AI · contact PI
HIV Treatment Failure and Drug Resistance in Western Kenyan Children$719,538
R01 · FY2018 · AI
Real Time Phylogeny and Contact Tracing to Disrupt HIV Transmission$715,662
R01 · FY2018 · AI · contact PI
Optimizing HIV Treatment Monitoring under Resource Constraints$680,826
R01 · FY2018 · AI
HIV Drug Resistance, Monitoring and Transmission$139,737
K24 · FY2018 · AI · contact PI
HIV Treatment Failure and Drug Resistance in Western Kenyan Children$702,147
R01 · FY2017 · AI
Optimizing HIV Treatment Monitoring under Resource Constraints$695,576
R01 · FY2017 · AI
HIV Treatment Failure and Drug Resistance in Western Kenyan Children$752,300
R01 · FY2016 · AI
Optimizing HIV Treatment Monitoring under Resource Constraints$708,750
R01 · FY2016 · AI
Optimizing HIV Treatment Monitoring under Resource Constraints$766,672
R01 · FY2015 · AI
HIV Drug Resistance Monitoring in Chennai, India$210,381
R21 · FY2014 · AI · contact PI
HIV Drug Resistance Monitoring in Chennai, India$206,875
R21 · FY2013 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$622,828
R01 · FY2012 · AI
HIV-1 Drug Resistance in Different Subtypes$811,418
R01 · FY2011 · AI
HIV-1 Drug Resistance in Different Subtypes$119,000
R01 · FY2011 · AI
HIV-1 Drug Resistance in Different Subtypes$639,331
R01 · FY2010 · AI
Antiretroviral Treatment Failure and Drug Resistance in HIV-infected Patients on$358,827
P30 · FY2010 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$626,417
R01 · FY2009 · AI
HIV-1 Drug Resistance in Different Subtypes$737,062
R01 · FY2008 · AI